Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

BioXcel Therapeutics (BTAI) Interest Coverage Ratio (2022 - 2025)

BioXcel Therapeutics (BTAI) has 4 years of Interest Coverage Ratio data on record, last reported at 3.62 in Q3 2025.

  • For Q3 2025, Interest Coverage Ratio rose 10.32% year-over-year to 3.62; the TTM value through Sep 2025 reached 3.3, up 32.85%, while the annual FY2024 figure was 4.59, 64.45% up from the prior year.
  • Interest Coverage Ratio reached 3.62 in Q3 2025 per BTAI's latest filing, up from 3.75 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 2.77 in Q1 2025 and bottomed at 4497.14 in Q1 2022.
  • Average Interest Coverage Ratio over 4 years is 309.04, with a median of 6.7 recorded in 2024.
  • The widest YoY moves for Interest Coverage Ratio: up 99.62% in 2023, down 79.21% in 2023.
  • A 4-year view of Interest Coverage Ratio shows it stood at 15.3 in 2022, then skyrocketed by 71.13% to 4.42 in 2023, then skyrocketed by 33.34% to 2.94 in 2024, then decreased by 22.94% to 3.62 in 2025.
  • Per Business Quant database, its latest 3 readings for Interest Coverage Ratio were 3.62 in Q3 2025, 3.75 in Q2 2025, and 2.77 in Q1 2025.